INSIGHTS ON CLINICAL TRIAL PARTNERING

• Building Bioanalysis Infrastructure For Modern Drug Development

  Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.

• Breaking Barriers: Enhancing The Bioavailability Of Orally Delivered TPDs

  The large, bulky structure of TPDs limits solubility and permeability. Enabling technologies like spray drying, hot melt extrusion, and nanomilling are key to formulating these challenging molecules.

• Reducing Human Variability in Bioanalysis

  Automation removes manual variability, creating consistent, repeatable processes that improve precision, strengthen compliance, and produce more reliable data for critical decisions.

• Unlocking Recruitment Potential In Trial-Naïve Sites

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

• Tips And Tricks For Developing Rare Cancer Clinical Trials

  2/6/2025

  Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.

• An Innovative Approach To Functional Outsourcing

  8/27/2025

  The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

• Why Use Scorecards To Make Vendor Selection Decisions

  10/21/2025

  Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.

• Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling

  3/12/2026

  See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.

• Navigating Biases In Clinical Trial Vendor Selection

  10/21/2025

  Biases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.